Steatohepatitis and hepatobiliary manifestations constitute some of the most common extraintestinal manifestations of Inflammatory Bowel Disease (IBD). On the other hand, non-alcoholic fatty liver disease (NAFLD) affects around 25% of the world’s population and is attracting ever more attention in liver transplant programs. To outline the specific pathways linking these two conditions is a pressing task for 21st-century researchers. We are accustomed to expecting the occurrence of fatty liver disease in obese people, but current evidence suggests that there are several different pathways also occurring in underweight patients. Genetic factors, inflammatory signals and microbiota are key players that could help in understanding the entire pathogenesis of NAFLD, with the aim of defining the multiple expressions of malnutrition. In the current review, we summarize the most recent literature regarding the epidemiology, pathogenesis and future directions for the management of NAFLD in patients affected by IBD.

Gibiino G., Sartini A., Gitto S., Binda C., Sbrancia M., Coluccio C., et al. (2021). The other side of malnutrition in inflammatory bowel disease (Ibd): Non-alcoholic fatty liver disease. NUTRIENTS, 13(8), 1-9 [10.3390/nu13082772].

The other side of malnutrition in inflammatory bowel disease (Ibd): Non-alcoholic fatty liver disease

Sartini A.;Gitto S.;Binda C.;Sambri V.;Fabbri C.
2021

Abstract

Steatohepatitis and hepatobiliary manifestations constitute some of the most common extraintestinal manifestations of Inflammatory Bowel Disease (IBD). On the other hand, non-alcoholic fatty liver disease (NAFLD) affects around 25% of the world’s population and is attracting ever more attention in liver transplant programs. To outline the specific pathways linking these two conditions is a pressing task for 21st-century researchers. We are accustomed to expecting the occurrence of fatty liver disease in obese people, but current evidence suggests that there are several different pathways also occurring in underweight patients. Genetic factors, inflammatory signals and microbiota are key players that could help in understanding the entire pathogenesis of NAFLD, with the aim of defining the multiple expressions of malnutrition. In the current review, we summarize the most recent literature regarding the epidemiology, pathogenesis and future directions for the management of NAFLD in patients affected by IBD.
2021
Gibiino G., Sartini A., Gitto S., Binda C., Sbrancia M., Coluccio C., et al. (2021). The other side of malnutrition in inflammatory bowel disease (Ibd): Non-alcoholic fatty liver disease. NUTRIENTS, 13(8), 1-9 [10.3390/nu13082772].
Gibiino G.; Sartini A.; Gitto S.; Binda C.; Sbrancia M.; Coluccio C.; Sambri V.; Fabbri C.
File in questo prodotto:
File Dimensione Formato  
The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease .pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Creative commons
Dimensione 272.4 kB
Formato Adobe PDF
272.4 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/872542
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact